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Gene Confirmation
Gene Identification and Selection
Transient Transfection
In each well:
•miRNA (mir-22-3p, negative control (NC) or 
si-killer)
•RNAiMAX + serum free DMEM
•Cells in 20% FBS DMEM
After 48 hrs harvest, assay, extract RNA, 
microarray
Fold Change
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• Mammalian cells are being used for producing 
proteins and antibodies for therapeutic, biochemical 
and structural studies. [2]
• Chinese Hamster Ovary (CHO) cells are commonly 
used for recombinant protein production but Human 
Embryonic Kidney (HEK-293) cells have the 
advantage of human post-translational modification.[3]
• microRNA (miRNA or miR) are small non-coding RNA 
that regulate gene expression. [4]
• Our previous high throughput screen identified 
several miRNA, which improve protein production in 
HEK cells with multiple protein types, from these we 
decided to concentrate on hsa-mir-22-3p. [6]
A. To improve protein expression in HEK 293 cells
B. To identify genes involved with improving protein 
expression as a result of treatment with the identified 
hsa-mir-22-3p
C. To create cell lines with improved protein expression
• miR-22-3p improves recombinant protein expression
• Using microarray analysis along with an siRNA 
screen, [7] common seed analysis and nCounter
analysis can identify genes involved in recombinant 
protein production
• HIPK1 is connected with improving luciferase and 
GPC3 expression
• Validated with siRNA and RT-PCR
• Investigate the mechanism(s) leading to improved 
protein biogenesis
• Create high producing cell line by stable knock-out of 
top candidate genes
• Compare to a high producing cell line with stable 
over-expressing mir-22
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Introduction Work Flow
Objectives
hsa-mir-22 secondary structure [4]  
Fig. 2 (A) Relative luminescence and cell viability of luciferase expressing HEK cells transiently transfected with mir-22-3p 
(B) Differentially expressed genes from microarray.  NC=Negative Control
Fig. 1 Work flow of gene identification, selection and confirmation for improving protein production. 
HTS = High throughput screen
Fig. 3 (A) Relative luminescence and cell viability of luciferase expressing HEK 293 cells treated with siRNA 
(B) Relative GPC3-hFc yield and cell viability of GPC3-hFC expressing HEK 293 cells treated with siRNA 
(B)
(B)
• 34,460 genes on microarray
• 405 differentially expressed
• 218 down regulated
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